UNQ Holdings (02177) Proprietary Brand Vanpearl Achieves Strong Performance in Singapore Market with Sales Exceeding RMB 4 Million

Stock News
Sep 11, 2025

From September 7 to 9, UNQ Holdings (02177) saw its Canadian health supplement brand Vanpearl achieve exceptional results in its Singapore market initiative in collaboration with "Macromolecule Laboratory," with total sales surpassing RMB 4 million and sales volume exceeding 8,000 bottles. On the first day of launch on September 7, the brand maintained its position at the top of TikTok's health supplement sales ranking, demonstrating outstanding live streaming traffic and conversion performance.

Vanpearl represents UNQ Holdings' key Canadian health supplement brand under development. Its flagship product, ERGO-VITALIS™ gene capsules, incorporates cutting-edge scientific research and innovative ingredients. The product features a patented formula designed for DNA repair and anti-aging benefits, capable of precisely activating cellular life factors, effectively replacing damaged DNA gene segments, and comprehensively protecting DNA genome stability. This approach fundamentally enhances cellular self-repair efficiency and metabolic efficiency, achieving anti-aging effects at the cellular DNA gene level, earning recognition as a "gene guardian."

The Singapore market initiative through Vanpearl's collaboration with Macromolecule Laboratory not only achieved strong performance in both traffic and conversion metrics but also further strengthened the brand's influence in the premium health supplement market. UNQ Holdings continues to leverage its integration capabilities across supply chain, brand operations, and cross-border e-commerce to promote connections between its proprietary brands and international scientific research resources.

Note: Sales and quantity data referenced covers September 7-9, sourced from Feigua platform. On September 7, the gene capsules Singapore research initiative maintained the top position on the health supplement sales chart from 8-9 PM during its launch debut.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10